| 专论编号 | 物质名称 | 证书持有人 | 持有人ORG-ID和LOC-ID | 证书编号 | 发布日期 | 证书状态 | 到期续期 | 证书结束日期 | 证书类型 | 上一程序的结束日期 | 历史数据 程序类型|结论|日期 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2287 | Fluconazole | FDC Limited Mumbai IN | 100011646;100021030 | CEP 2016-286 - Rev 01 | 2026/02/19 | Valid | Chemical | 2026/02/19 | Monograph revision|CEP granted|19/02/2026; Renewal|CEP granted|04/07/2023; Minor revision|Accepted - CEP remains valid|27/10/2022 |
||
| 1694 | Gemfibrozil | HIKAL LIMITED Bengaluru IN | 100014769;100023445 | CEP 2007-089 - Rev 06 | 2026/02/19 | Valid | Chemical | 2026/02/19 | Minor revision|CEP granted|19/02/2026; Minor revision|Accepted - CEP remains valid|23/01/2023; Notification|Rejected|06/12/2022; Notification|CEP granted|07/09/2022; Minor revision|Accepted - CEP remains valid|20/02/2020 |
||
| 562 | Sodium cromoglicate | SANOFI AVENTIS SINGAPORE PTE LTD Singapore SG | 100005144;100008271 | CEP 2001-421 - Rev 04 | 2026/02/19 | Valid | Chemical | 2026/02/19 | Notification|CEP granted|19/02/2026; Minor revision|Accepted - CEP remains valid|10/08/2022; Monograph revision|Accepted - CEP remains valid|16/06/2021 |
||
| 1096 | Doxepin hydrochloride | TAPI NL B.V. Amsterdam NL | 100003852;100094134 | CEP 1999-197 - Rev 06 | 2026/02/19 | Valid | Chemical | 2026/02/19 | Major revision|CEP granted|19/02/2026; Minor revision|CEP granted|07/05/2025; Minor revision|Accepted - CEP remains valid|26/06/2023; Minor revision|CEP granted|08/12/2021; Minor revision|Accepted - CEP remains valid|12/06/2020 |
||
| 568 | Propranolol hydrochloride | IPCA LABORATORIES LIMITED Mumbai IN | 100011685;100018680 | CEP 2002-026 - Rev 07 | 2026/02/19 | Valid | Chemical | 2026/02/19 | Minor revision|CEP granted|19/02/2026; Minor revision|CEP granted|06/12/2023; Notification|CEP granted|03/08/2023; Minor revision|CEP granted|22/05/2023; Minor revision|Accepted - CEP remains valid|15/07/2022; Minor revision|CEP granted|21/09/2021; Minor revision|Accepted - CEP remains valid|01/04/2021; Minor revision|Accepted - CEP remains valid|13/03/2020 |
||
| 576 | Allopurinol | EXEMED PHARMACEUTICALS Vadodara IN | 100019154;100027915 | CEP 2021-331 - Rev 01 | 2026/02/19 | Valid | 30/11/2027 | Chemical | 2026/02/19 | Minor revision|CEP granted|19/02/2026; Notification|Rejected|26/11/2025; New application|CEP granted|01/12/2022 |
|
| 3087 | Ticagrelor | ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. Taizhou City CN | 100011825;100018687 | CEP 2024-020 - Rev 00 | 2026/02/19 | Valid | 19/02/2031 | Chemical | 2026/02/19 | New application|CEP granted|19/02/2026 | |
| 1792 | Nicotine resinate, Nicotine content 18% with glycerol 9.0-11.0% | ALCHEM INTERNATIONAL PRIVATE LIMITED Faridabad IN | 100011947;100018683 | CEP 2019-030 - Rev 03 | 2026/02/19 | Valid | Chemical | 2026/02/19 | Minor revision|CEP granted|19/02/2026; Renewal|Accepted - CEP remains valid|17/10/2025; Minor revision|CEP granted|19/05/2025; Minor revision|CEP granted|01/08/2022; Notification|Rejected|23/02/2022 |
||
| 2858 | Mometasone furoate monohydrate, Micronised and non-micronised | BREATHGREEN PHARMACEUTICAL CO. LTD. Zaozhuang CN | 100048781;100081153 | CEP 2025-357 - Rev 00 | 2026/02/19 | Valid | 19/02/2031 | Chemical | 2026/02/19 | New application|CEP granted|19/02/2026 | |
| 2606 | Tadalafil | SHANDONG CHENGHUI SHUANGDA PHARMACEUTICAL CO., LTD. Dezhou CN | 100048410;100080174 | CEP 2025-131 - Rev 01 | 2026/02/19 | Valid | 22/10/2030 | Chemical | 2026/02/19 | Minor revision|CEP granted|19/02/2026; New application|CEP granted|22/10/2025 |
|
| 2600 | Olmesartan medoxomil | TORRENT PHARMACEUTICALS LIMITED Ahmedabad IN | 100004452;100001862 | CEP 2023-126 - Rev 00 | 2026/02/19 | Valid | 19/02/2031 | Chemical | 2026/02/19 | New application|CEP granted|19/02/2026 | |
| 1425 | Fosfomycin trometamol | GUILIN HWASUN PHARMACEUTICAL CO., LTD. Guilin CN | 100034192;100054092 | CEP 2025-152 - Rev 00 | 2026/02/19 | Valid | 19/02/2031 | Chemical | 2026/02/19 | New application|CEP granted|19/02/2026 | |
| 2857 | Trazodone hydrochloride, Process-II, Milled/Unmilled | INTAS PHARMACEUTICALS LIMITED Ahmedabad IN | 100011529;100023432 | CEP 2025-141 - Rev 02 | 2026/02/19 | Valid | 13/11/2030 | Chemical | 2026/02/19 | Administrative procedure|CEP granted|19/02/2026; Minor revision|CEP granted|03/02/2026; New application|CEP granted|13/11/2025 |
|
| 50 | Procaine Hydrochloride | FLARER S.A. Balerna CH | 100047920;100079248 | CEP 2021-223 - Rev 03 | 2026/02/19 | Valid | 14/11/2027 | Chemical | 2026/02/19 | Monograph revision|CEP granted|19/02/2026; Minor revision|Accepted - CEP remains valid|03/12/2025; Minor revision|CEP granted|24/02/2025; Minor revision|CEP granted|02/02/2024; New application|CEP granted|14/11/2022 |
|
| 52 | Rifampicin | OLON S.P.A. Rodano IT | 100012085;100019537 | CEP 2009-275 - Rev 06 | 2026/02/18 | Valid | Chemical | 2026/02/18 | Minor revision|CEP granted|18/02/2026; Minor revision|CEP granted|27/05/2024; Minor revision|CEP granted|27/07/2022; Major revision|CEP granted|24/11/2021 |
||
| 1756 | Lamotrigine | ALEMBIC PHARMACEUTICALS LIMITED Vadodara IN | 100006039;100002980 | CEP 2011-010 - Rev 06 | 2026/02/18 | Valid | Chemical | 2026/02/18 | Minor revision|CEP granted|18/02/2026; Minor revision|CEP granted|03/02/2025; Minor revision|CEP granted|12/07/2024; Notification|CEP granted|19/06/2023; Minor revision|CEP granted|18/02/2022; Minor revision|CEP granted|06/04/2020 |
||
| 179 | Erythromycin, Micronised, powder | ERCROS S.A. Aranjuez ES | 100016091;100024873 | CEP 2003-129 - Rev 03 | 2026/02/18 | Valid | Chemical | 2026/02/18 | Minor revision|CEP granted|18/02/2026; Major revision|Rejected|04/11/2025; Monograph revision|CEP granted|26/03/2021 |
||
| 1615 | Finasteride | SHAKTI LIFESCIENCE PRIVATE LIMITED Mumbai IN | 100048889;100089578 | CEP 2023-335 - Rev 00 | 2026/02/18 | Valid | 18/02/2031 | Chemical | 2026/02/18 | New application|CEP granted|18/02/2026 | |
| 1275 | Ursodeoxycholic acid | ZHONGSHAN BELLING BIOTECHNOLOGY CO., LTD. Zhongshan City CN | 100039390;100062018 | CEP 2018-237 - Rev 02 | 2026/02/18 | Valid | Chemical | 2026/02/18 | Monograph revision|CEP granted|18/02/2026; Renewal|CEP granted|10/07/2024; Notification|Accepted - CEP remains valid|26/09/2023 |
||
| 579 | Aprotinin concentrated solution, Activity: 100 - 136 Ph. Eur. Units of aprotinin activity per mL Bacterial endotoxin free | PENTAPHARM AG Aesch CH | 100025404;100052203 | CEP 2002-095 - Rev 08 | 2026/02/18 | Valid | Chemical and TSE | 2026/02/18 | Monograph revision|CEP granted|18/02/2026; Monograph revision|CEP granted|20/03/2025; Notification|Accepted - CEP remains valid|17/07/2023; Transfer of holdership|CEP granted|30/06/2023; Notification|Accepted - CEP remains valid|04/04/2022; Monograph revision|CEP granted|23/02/2022; Minor revision|Accepted - CEP remains valid|27/11/2020 |
请输入需要查询的英文物质名称,证书持有人,证书编号,专论编号